HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Danielle E Antin-Ozerkis Selected Research

PRM-151

1/2019Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Danielle E Antin-Ozerkis Research Topics

Disease

2Idiopathic Pulmonary Fibrosis
01/2019 - 12/2017
2Disease Progression
12/2018 - 12/2017
1Lung Diseases (Lung Disease)
01/2021
1COVID-19
01/2021

Drug/Important Bio-Agent (IBA)

1Proteins (Proteins, Gene)FDA Link
01/2019
1PRM-151IBA
01/2019
1Mitochondrial DNA (mtDNA)IBA
12/2017

Therapy/Procedure

1Critical Care (Surgical Intensive Care)
01/2021
1Therapeutics
12/2018